



Biology, Medicine, & Natural Product Chemistry  ISSN 2089-6514 (paper) 





Stability Analysis of Mathematical Modeling of Interaction between 
Target Cells and COVID-19 Infected Cells 
 
Sugiyanto1*, Mansoor Abdul Hamid2, Alya Adianta1, Hanny Puspha Jayanti1, Muhammad Ja'far Luthfi3 
1Mathematics Department, Faculty of Science and Technology, Universitas Islam Negeri Sunan Kalijaga, Indonesia. 
2School of Food Science & Nutrition, Universiti Malaysia Sabah, Malaysia. 











The stability analysis in this mathematical model was related to the infection of the Coronavirus Disease 2019 (Covid-19). In this 
mathematical model there were two balance points, namely the point of balance free from Covid-19 and the one infected with Covid-19. 
The stability of the equilibrium point was influenced by all parameters, i.e. target cells die during each cycle, number of target cells at 𝑡′ = 
0, target cells infected during each cycle based on virion unit density, effective surface area of the network, the ratio of the number of 
virus particles to the number of virions, infected cells die during each cycle, the number of virus particles produced by each infected cell 
during each cycle, and virus particles die during each cycle. In the simulation model, immunity is divided into high, medium and low 
immunity. For high, moderate and low immunity, respectively, the highest number of target cells is in high, medium and low immunity, 
whereas for the number of infected cells and the number of Covid-19, it is in the opposite sequence of the number of target cells. 
 





Coronavirus Disease 2019 (Covid-19) was first known 
to infect residents in Wuhan City, China, and was 
notified by the Chinese Government to WHO in 
December 2019 (Sugiyanto & Abrori, 2020). Covid-19 
belongs to subfamily Orthocoronavirinae, family 
Coronaviridae, and order Nidovirales (Tan et. al., 2020). 
About 80% of Covid-19 illness show mild symptoms 
and 20% have severe symptoms. Some of the 20% 
patients who contract Covid-19 develop severe 
pneumonia, sometimes with acute respiratory distress, 
which can lead to organ failure and death. 
The stability analysis of mathematical modeling is 
used to determine the recovery period of Covid-19 
patients. There are many factors that determine a person 
would get into mild, severe or severe symptoms. We can 
classify these symptoms into three things depend on the 
immunity of the Covid-19 patient. In this modeling, 
categorization were done using the T – I – V model. The 
target cell subpopulation (T) is cells in several organs, 
such as the lungs, heart, arteries, intestines and kidneys. 
The Infected cell subpopulation (I) is a cell that is 
infected through a receptor on the surface called 
Angiotensin Converting Enzyme 2 (ACE2) (Diaz, 
2020). Target cells were epithelial cells in all of these 
organs. This target cell was ACE2. The conversion of 
angiotensin II (vasoconstruction peptide) to angiotensin 
1-7 (vasodilator) was catalyzed by ACE2 (Zhang et. al., 
2020). 83% of normal lung cells express ACE2, namely 
type II alveolar epithelial cells (AECII), which make 
these cells viral reservoirs. The spike protein (shaped 
like a nail) stuck to the surface of the SARS-CoV virus 
(Zoufaly et. al., 2020). The ACE2 enzyme attaches to 







The Mathematical Model obtained in System (1) refers 


















= (𝑝𝜏)𝐼 − (𝑐𝜏)𝑉 (1c) 
 
 
Description of the target cell subpopulation, Covid-
19 infected cells, virus population and parameters are 
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Table 1. Target cell subpopulation, Covid-19 infected cells, virus 
population and parameters. 
 
No. Symbol Explanation  Unit 
1 𝜏 Average cycle time for viral 
replication 
𝑑𝑎𝑦 
2 𝑡′ = 𝑡/𝜏 Number of virus replication 
cycles   
- 
3 𝑇 Number of target cells at 𝑡′ 𝑐𝑒𝑙𝑙 
4 𝐼 Number of infected cells at 𝑡′ 𝑐𝑒𝑙𝑙 
5 𝑉 Number of virus particles at 𝑡′ 𝑣𝑖𝑟𝑢𝑠 
6 (𝑑𝜏) Target cells die during each 
cycle 
- 
7 𝑇0 Number of target cells at 𝑡
′ = 0 𝑐𝑒𝑙𝑙 
8 (𝑘𝜏) Target cells infected during 
each cycle based on virion unit 
density 
- 
9 𝐴 Effective surface area of the 
network 
𝑚𝑚2 
10 𝛼 The ratio of the number of 




11 (𝛿𝜏) Infected cells die during each 
cycle 
- 
12 (𝑝𝜏) The number of virus particles 
produced by each infected cell 
during each cycle 
- 




Theorem 1. Equilibrium Point 
There are two equilibrium points of System (1), namely: 
free from the Covid-19 virus and infected with the 
Covid-19 virus. The Covid-19 virus-free equilibrium 
point is  
𝐸𝑃0 = (𝑇, 𝐼, 𝑉) = (𝑇0, 0,0). 
 
The equilibrium point for contracting the Covid-19 virus 
is  

















From Equation (1a) and 
𝑑𝑇
𝑑𝑡′







From Equation (1c) and 
𝑑𝑉
𝑑𝑡′










= 0 and substituting equations (2) and (3) into 
equation (1), we get 
 




= 𝑎3 (5) 
From Equation (2) and Equation (4), we get  
𝑇 = 𝑇0.  (6) 
From Equation (3) and Equation (4), we get  
𝐼 = 0.  (7) 
From Equations (6), (7) and (4) it is proven that the 
Covid-19 virus-free equilibrium point is 𝐸𝑃0.  
If Equation (5) is substituted into Equation (2), then 





= 𝑎1 (8) 






= 𝑎2 (9) 
From Equations (8), (9) and (5) it is proven that the 
equilibrium point for contracting the Covid-19 virus is 
𝐸𝑃1. ■ 
From Theorem 1 it can be conveyed, if there is no 
Covid-19 virus then someone will be safe or someone is 
virus free, and if there is a virus then a person's healing 
point is influenced by all parameters. Virus-free can be 
achieved if there is no person carrying the virus or 
complying with health procedures such as wearing a 
mask, keeping a distance and washing hands as often as 
possible. When a person gets a virus, only the immune 
(target cells) can fight the infected cells.  
 
Theorem 2. Existence of the Equilibrium Point 
Existence 𝐸𝑃0 fulfilled in any non-negative number 
parameter and existence 𝐸𝑃1 fulfilled if  
 
(𝑘𝜏)𝑇0(𝑝𝜏) − (𝛿𝜏)(𝑐𝜏)𝐴𝛼 > 0. 
 
Proof. 
From Theorem 1, that existence 𝐸𝑃0 and 𝐸𝑃1 proven. ■ 
From Theorem 2 it can be seen that all parameters do 
not affect the existence of the equilibrium point 𝐸𝑃0. All 
parameters are target cells die during each cycle, number 
of target cells at 𝑡′ = 0, target cells infected during each 
cycle based on virion unit density, effective surface area 
of the network, the ratio of the number of virus particles 
to the number of virions, infected cells die during each 
cycle, the number of virus particles produced by each 
infected cell during each cycle, and virus particles die 
during each cycle. This means that if a person is not 
exposed to the Covid-19 virus, the target cells would not 
affected or the condition of a person is healthy without 
the virus. For someone who is infected with the virus, all 
parameters affect the existence of the equilibrium point 
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healthy or even die depending on the target cells 
working well or not.  
 
Theorem 3. Stability of the Equilibrium Point 





− ((𝛿𝜏) + (𝑐𝜏)), 
then the equilibrium point 𝐸𝑃0 is locally 
asymptotically stable. 





























= (𝑝𝜏)𝐼 − (𝑐𝜏)𝑉  (10c) 
 
Jacobian matrix function 𝑓 from System (10) written can 
be obtained by first performing the partial derivation of 
the functions 
 
𝑓1 = (𝑇, 𝐼, 𝑉 )  (11a) 
𝑓2 = (𝑇, 𝐼, 𝑉  ) (11b) 
𝑓3 = (𝑇, 𝐼, 𝑉  ) (11c) 
 
as follows. 






𝑉;     
𝜕𝑓1
𝜕𝐼










𝑉;     
𝜕𝑓2
𝜕𝐼







(iii). Partial derivative 𝑓3 with respect to 𝑇, 𝐼, 𝑉 namely: 
𝜕𝑓3
𝜕𝑇
= 0;     
𝜕𝑓3
𝜕𝐼





The Jacobian matrix is 





































We find the eigenvalues of 𝐽(𝑇0, 0,0) that is 𝜆𝑖, for 𝑖 =
1,2,3, where 
 0 ,0,0 0.J T I   
We get the eigenvalues of the Jacobian Matrix which is 
represented by  
 
         
  



























   

 







   
  
 








We know that ((𝛿𝜏) − (𝑐𝜏))
2
≥ 0 and 
(𝑘𝜏)(𝑝𝜏)𝑇0
𝐴𝛼
> 0, so 





> 0.  
Since the parameters are greater than zero, we get
  1 20, 0,    
















)] < 0. 
We get all negative eigenvalues, so that 𝐸𝑃0 is locally 
asymptotically stable. 
 
(2) For 𝑬𝑷𝟏, we get 





















We find the eigenvalues of 𝐽(𝑎1, 𝑎2, 𝑎3) that is 𝜆𝑖, for 
𝑖 = 1,2,3, where 
 1 2 3, 0.,J a a a I   
We get the eigenvalues of the Jacobian Matrix which is 
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   

 









   
  
 









We know that ((𝛿𝜏) − (𝑐𝜏))
2
≥ 0 and 
(𝑘𝜏)(𝑝𝜏)𝑇0
𝐴𝛼






> 0.  
Since the parameters are greater than zero, we get  
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((𝛿𝜏) + (𝑐𝜏)) < 0, then we get  
         






















We get all negative eigenvalues, so that 𝐸𝑃1 is locally 
asymptotically stable.■ 
From Theorem 3 the stability point is affected by all 
parameters. This means that a person will recover 
depending on the target cells that work. The better the 
target cells work, the healthier the person would be and 






The parameters in this simulation are taken from Du and 
Yuan's (2020) paper. Table 2 shows the parameter 
values. In this simulation, we replace the symbol (𝑝𝜏) 
with 𝑏. This is because in Matlab there is no Insert 
Legend that can be written (𝑝𝜏). 
 
Table 2. Parameter values for simulation. 
 
No. Parameter Value 
1 𝜏 7 







5 𝛿𝜏 0.4 
6 𝑐𝜏 0.4 
7 𝐼0 10 




Figure 1. Changes in the number of target cells against the presence of the 
Covid-19 virus. 
 
Target cells reflect the number of cells in people with 
three conditions, namely: low, moderate and high 
immunity conditions. Figure 1, Figure 2 and Figure 3 
represent person with high immunity ((𝑝𝜏) = 𝑏 = 50), 
moderate immunity ((𝑝𝜏) = 𝑏 = 100), and low 
immunity ((𝑝𝜏) = 𝑏 = 150). Person with good 
immunity shows the target cell from 10,000,000 cells in 
13.09 days to 101,800 cells. Person with moderate 
immunity shows the target cell from 10,000,000 cells in 
8,514 days to 104,300 cells. Person with low immunity 
shows the target cell from 10,000,000 cells in 2,398 
days to 105,000 cells. The order of decline in target cells 
from the longest to the fastest is good, medium and low 
immunity. Table 3 describes the descending order of the 
target cells. 
 
Table 3. Target cell decrease. 
 









1 High 10,000,000 101,800 13.09 
2 Medium 10,000,000 104,300 8.514 





Figure 2. Changes in the number of infected cells against the presence of 
the Covid-19 virus. 
 
Figure 2 shows the peak number of infected cells 
differed between individuals with high, moderate and 
low immunity. A person with low immunity on day 
6,155 the number of infected is 7.146 × 107 cell. A 
person with moderate immunity on day 7,685 the 
number of infected is 6.65 × 107 cell. A person with 
high immunity on day 11.46 the number of infected is 
5.655 × 107 cell. Briefly, this explanation is in Table 4. 
 
Table 4. Increase in the number of infected cells. 
 
No. Immunity  




1 High 5.655 × 107 11.46 
2 Medium 6.65 × 107 7.685 
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Figure 3 shows the number of viruses with high, 
medium and low immunity conditions. For someone 
with high immunity the maximum virus count on day 
13.19 is 4.31 × 108 virus. For someone with moderate 
immunity the maximum virus count on 9,492 days is 
8.946 × 109 virus. For a person with low immunity the 
maximum viral load on day 8,068 is 1.356 × 1010 
virus. Table 5 describes the amount of virus in the 
condition of a person with high, medium and low 
immunity. 
 
Table 5. Increase in the number of virus particles. 
 
No. Immunity 
Highest number of 
viruses (virus) 
Time (day) 
1 High 4.31 × 108 13.19 
2 Medium 8.946 × 109 9.492 





The stability of being free of the Covid-19 virus and 
infected with the virus is influenced by all parameters. 
The number of target cells, virus-infected cells and virus 
particles is affected by a person's immunity. If a person 
has high immunity, the number of target cells would 
decrease slowly. Vice versa, if a person has low 
immunity, then the number of target cells will drop 
rapidly. In a person having low immunity, the infected 
cells and viruses will quickly increase in number 
compared to the one with high immunity. 
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